
    <rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
      <channel>
        <title>Articles tagged with Food and Drug Administration from McKnight's Long Term Care News</title>
        <link>http://www.mcknights.com/food-and-drug-administration/topic/3646/</link>
        <description>Articles tagged with Food and Drug Administration from McKnight's Long Term Care News</description>
        <itunes:author>McKnight's</itunes:author>
        <itunes:subtitle></itunes:subtitle>
        <itunes:summary></itunes:summary>
        <itunes:owner>
            <itunes:name></itunes:name>
            <itunes:email>custserv@mcknights.com</itunes:email>
        </itunes:owner>
        <itunes:category text="BUSINESS">
            <itunes:category text="BUSINESS NEWS" /> 
        </itunes:category> 
        <itunes:image href='http://media.haymarketmedia.com/images/45/MCK_Mobile_logo_44402.gif'></itunes:image>
        <itunes:explicit>no</itunes:explicit>
  
        <item>
          <title>Fecal transplants to treat C. diff now need FDA approval  </title>
          <description>The Food and Drug Administration is moving to tighten regulations around fecal transplants, which research has shown to be an effective treatment for Clostridium difficile infection.</description>
          <link>http://www.mcknights.com/fecal-transplants-to-treat-c-diff-now-need-fda-approval/article/293722/</link>
          <pubDate>Fri, 17 May 2013 10:30:00 GMT</pubDate>
          <itunes:summary>The Food and Drug Administration is moving to tighten regulations around fecal transplants, which research has shown to be an effective treatment for Clostridium difficile infection.</itunes:summary>
          <itunes:author>McKnight's</itunes:author>
          
        </item>
  
        <item>
          <title>FDA approves new oral drug to relieve constipation from opioid painkillers</title>
          <description>Long-term care residents who experience constipation from taking opioids to manage chronic pain may benefit from Amitiza, an oral drug recently approved by the Food and Drug Administration.</description>
          <link>http://www.mcknights.com/fda-approves-new-oral-drug-to-relieve-constipation-from-opioid-painkillers/article/290228/</link>
          <pubDate>Wed, 24 Apr 2013 10:30:00 GMT</pubDate>
          <itunes:summary>Long-term care residents who experience constipation from taking opioids to manage chronic pain may benefit from Amitiza, an oral drug recently approved by the Food and Drug Administration.</itunes:summary>
          <itunes:author>McKnight's</itunes:author>
          
        </item>
  
        <item>
          <title> Court upholds $142 million Neurontin verdict</title>
          <description>Pfizer must pay $142 million for the marketing and prescribing of epilepsy drug Neurontin for unapproved uses, a federal appeals court has ruled.</description>
          <link>http://www.mcknights.com/court-upholds-142-million-neurontin-verdict/article/288154/</link>
          <pubDate>Wed, 10 Apr 2013 11:00:00 GMT</pubDate>
          <itunes:summary>Pfizer must pay $142 million for the marketing and prescribing of epilepsy drug Neurontin for unapproved uses, a federal appeals court has ruled.</itunes:summary>
          <itunes:author>McKnight's</itunes:author>
          
        </item>
  
        <item>
          <title>Feds should tighten access to common painkillers, legislators say</title>
          <description>The Food and Drug Administration should &quot;act without delay&quot; in tightening access to hydrocodone painkillers such as Vicodin, Congressional lawmakers urged in a recent letter. The letter was written by Sen. Joe Manchin (D-WV) and signed by a bipartisan group of five other senators and two representatives.</description>
          <link>http://www.mcknights.com/feds-should-tighten-access-to-common-painkillers-legislators-say/article/281999/</link>
          <pubDate>Wed, 27 Feb 2013 11:30:00 GMT</pubDate>
          <itunes:summary>The Food and Drug Administration should &quot;act without delay&quot; in tightening access to hydrocodone painkillers such as Vicodin, Congressional lawmakers urged in a recent letter. The letter was written by Sen. Joe Manchin (D-WV) and signed by a bipartisan group of five other senators and two representatives.</itunes:summary>
          <itunes:author>McKnight's</itunes:author>
          
        </item>
  
        <item>
          <title>Becoming wide awake about the dangers of sleeping pills</title>
          <description>There are some people who are able to fall asleep as their head is hitting the pillow. Then there are the rest of us. And if you don&apos;t think you know any of us, you&apos;re probably wrong.</description>
          <link>http://www.mcknights.com/becoming-wide-awake-about-the-dangers-of-sleeping-pills/article/276023/</link>
          <pubDate>Tue, 15 Jan 2013 10:30:00 GMT</pubDate>
          <itunes:summary>There are some people who are able to fall asleep as their head is hitting the pillow. Then there are the rest of us. And if you don&apos;t think you know any of us, you&apos;re probably wrong.</itunes:summary>
          <itunes:author>McKnight's</itunes:author>
          
        </item>
  
        <item>
          <title>FDA orders recommended dosages of sleeping pills to be halved</title>
          <description>The Food and Drug Administration is requiring manufacturers of certain sleeping pills, including the widely prescribed Ambien, to reduce current recommended dosages.</description>
          <link>http://www.mcknights.com/fda-orders-recommended-dosages-of-sleeping-pills-to-be-halved/article/275834/</link>
          <pubDate>Mon, 14 Jan 2013 11:00:00 GMT</pubDate>
          <itunes:summary>The Food and Drug Administration is requiring manufacturers of certain sleeping pills, including the widely prescribed Ambien, to reduce current recommended dosages.</itunes:summary>
          <itunes:author>McKnight's</itunes:author>
          
        </item>
  
        <item>
          <title>Invacare signs consent decree to correct wheelchair manufacturing problems</title>
          <description>Invacare has signed a consent decree in which the company will fix wheelchair manufacturing problems, the Food and Drug Administration announced.</description>
          <link>http://www.mcknights.com/invacare-signs-consent-decree-to-correct-wheelchair-manufacturing-problems/article/273886/</link>
          <pubDate>Wed, 02 Jan 2013 11:00:00 GMT</pubDate>
          <itunes:summary>Invacare has signed a consent decree in which the company will fix wheelchair manufacturing problems, the Food and Drug Administration announced.</itunes:summary>
          <itunes:author>McKnight's</itunes:author>
          
        </item>
  
        <item>
          <title>Unapproved marketing of pressure ulcer drug brings settlement worth up to $48 million   </title>
          <description>The unapproved bed sore drug Xenaderm, which was marketed to nursing homes as &quot;Medicaid reimbursed,&quot; is the source of a settlement that could reach $48 million for Healthpoint Ltd. and DFB Pharmaceuticals.</description>
          <link>http://www.mcknights.com/unapproved-marketing-of-pressure-ulcer-drug-brings-settlement-worth-up-to-48-million/article/271816/</link>
          <pubDate>Mon, 10 Dec 2012 11:30:00 GMT</pubDate>
          <itunes:summary>The unapproved bed sore drug Xenaderm, which was marketed to nursing homes as &quot;Medicaid reimbursed,&quot; is the source of a settlement that could reach $48 million for Healthpoint Ltd. and DFB Pharmaceuticals.</itunes:summary>
          <itunes:author>McKnight's</itunes:author>
          
        </item>
  
        <item>
          <title>GSK agrees to pay $90 million to settle diabetes drug allegations</title>
          <description>GlaxoSmithKline will pay a $90 million settlement to 38 states that claimed it unlawfully promoted its diabetes treatment Avandia (rosiglitazone). The attorneys general of several states confirmed the action on Thursday.</description>
          <link>http://www.mcknights.com/gsk-agrees-to-pay-90-million-to-settle-diabetes-drug-allegations/article/268887/</link>
          <pubDate>Mon, 19 Nov 2012 11:30:00 GMT</pubDate>
          <itunes:summary>GlaxoSmithKline will pay a $90 million settlement to 38 states that claimed it unlawfully promoted its diabetes treatment Avandia (rosiglitazone). The attorneys general of several states confirmed the action on Thursday.</itunes:summary>
          <itunes:author>McKnight's</itunes:author>
          
        </item>
  
        <item>
          <title>Senator calls for an end to misleading wheelchair and scooter advertisements</title>
          <description>The aggressive marketing of power wheelchairs and scooters to seniors drives up Medicare costs and puts providers in a tough spot, says Sen. Richard Blumenthal (D-CT).</description>
          <link>http://www.mcknights.com/senator-calls-for-an-end-to-misleading-wheelchair-and-scooter-advertisements/article/264311/</link>
          <pubDate>Fri, 19 Oct 2012 10:30:00 GMT</pubDate>
          <itunes:summary>The aggressive marketing of power wheelchairs and scooters to seniors drives up Medicare costs and puts providers in a tough spot, says Sen. Richard Blumenthal (D-CT).</itunes:summary>
          <itunes:author>McKnight's</itunes:author>
          
        </item>
  
      </channel>
    </rss>  
  